Our consortium is highly interdisciplinary, covering expertise in biochemistry and signaling, structural biology, medicinal chemistry and structure-guided drug design, cancer immunology and inflammation, mouse models, cancer genomics, computational genomics, molecular pathology, as well as clinical trials.
SFB 1399
Mechanisms of Drug Sensitivity
and Resistance in Small Cell Lung Cancer
c/o Department of Translational Genomics
University of Cologne
Weyertal 115b
50931 Cologne, Germany